Skip to main content
. 2018 Dec 19;7(2):e10313. doi: 10.2196/10313

Table 1.

Blood-borne virus screening and infection status.

Outcome Total (n=134), n (%)
HCVa Abb test—lifetime 127 (94.8)
HCV Ab positive—lifetime 99 (73.9)
HCV Ab test—past year 32 (23.9)
HCV Ab positive—past year 23 (17.2)
HIV Ab test—lifetime 112 (83.6)
HIV Ab positive—lifetime 7 (5.2)
HIV Ab test—past year 34 (25.4)
HIV Ab positive—past year 1 (0.7)
Anti-HBcc or BsAgd test—lifetime 89 (66.4)
Anti-HBc or HBsAg positive—lifetime 7 (5.2)
Anti-HBc or HBsAg test—past year 30 (22.4)
Anti-HBc or HBsAg positive—past year 1 (0.7)

aHCV: hepatitis C virus.

bAb: antibody.

canti-HBc: hepatitis B core antibody.

dHBsAg: hepatitis B surface antigen.